News for July 15th, 2009

Device offers alternative treatment for gastroparesis

An electrical stimulation device to speed up the digestion in overweight patients with type 2 diabetes is showing promising results in the improvement of glycemic control, according to Med Page Today. The device works by discharging electrical current into the gastric antrum. It was originally developed as a nonpharmacologic alternative for treatment of , which is often treated with the medication Reglan (metoclopramide).

Some patients with don’t respond to treatment and some may experience severe adverse events from the medication. For example, Reglan recently fell under a black box warning after reports of a serious movement disorder called Tardive Dyskinesia in some patients who took the medication. Given the risks of medication, alternative therapies like the stimulation device seem more attractive. 

Read the rest of this entry »

FDA approves Reglan label changes to reflect black box warning

tablet FDA approves Reglan label changes to reflect black box warning The Food and Drug Administration (FDA) has approved the safety labeling changes of the heartburn and medication Reglan (metoclopramide) which includes a black box warning of a serious and often irreversible movement disorder called Tardive Dyskinesia. The warning includes Reglan (metoclopramide) tablets, ODT (orally disintegrating tablets), and injection.

Read the rest of this entry »